Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update on Malignant Melanoma Vaccine Research
Stephen J. Ralph
American Journal of Clinical Dermatology (2007) Vol. 8, Iss. 3, pp. 123-141
Closed Access | Times Cited: 21

Showing 21 citing articles:

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil Senzer, Howard L. Kaufman, Thomas Amatruda, et al.
Journal of Clinical Oncology (2009) Vol. 27, Iss. 34, pp. 5763-5771
Open Access | Times Cited: 597
Dormancy of metastatic melanoma
Liliana Ossowski, Julio A. Aguirre‐Ghiso
Pigment Cell & Melanoma Research (2009) Vol. 23, Iss. 1, pp. 41-56
Open Access | Times Cited: 130
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
Kimberley Stannard, P.M. Collins, Koichi Ito, et al.
Cancer Letters (2010) Vol. 299, Iss. 2, pp. 95-110
Closed Access | Times Cited: 100
Phosphoproteomics and cancer research
Keith Ashman, Elena López Villar
Clinical & Translational Oncology (2009) Vol. 11, Iss. 6, pp. 356-362
Closed Access | Times Cited: 55
Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma
Monica Neagu, Carolina Constantin, Cristiana Tănase
Expert Review of Molecular Diagnostics (2010) Vol. 10, Iss. 7, pp. 897-919
Closed Access | Times Cited: 49
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC
Leona L. Pott, Sascha Hagemann, Henning Reis, et al.
Oncotarget (2017) Vol. 8, Iss. 7, pp. 11950-11962
Open Access | Times Cited: 36
Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
Yi‐Ting Wang, Szu‐Hua Pan, Chia-Feng Tsai, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Herpes simplex virus oncolytic vaccine therapy in melanoma
Shanthi Sivendran, Michael Pan, Howard L. Kaufman, et al.
Expert Opinion on Biological Therapy (2010) Vol. 10, Iss. 7, pp. 1145-1153
Closed Access | Times Cited: 31
Cell Proliferation in Cutaneous Malignant Melanoma: Relationship with Neoplastic Progression
Gérald Pierard
ISRN Dermatology (2012) Vol. 2012, pp. 1-12
Open Access | Times Cited: 27
BAP31, a promising target for the immunotherapy of malignant melanomas
Shaojuan Yu, Fuli Wang, Li Fan, et al.
Journal of Experimental & Clinical Cancer Research (2015) Vol. 34, Iss. 1
Open Access | Times Cited: 24
Malignant Melanoma
Pascale Quatresooz, Gérald Pierard
American Journal of Clinical Dermatology (2011) Vol. 12, Iss. 2, pp. 77-86
Closed Access | Times Cited: 15
Apurinic/Apyrimidinic Endonuclease/Redox Effector Factor-1(APE/Ref-1): A Unique Target for the Prevention and Treatment of Human Melanoma
Sun Yang, Frank L. Meyskens
Antioxidants and Redox Signaling (2008) Vol. 11, Iss. 3, pp. 639-650
Open Access | Times Cited: 15
Phosphoproteomics and Lung Cancer Research
Elena López‐Camacho, Yong‐Yeon Cho
International Journal of Molecular Sciences (2012) Vol. 13, Iss. 10, pp. 12287-12314
Open Access | Times Cited: 11
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
Kimberley L. Kaufman, Swetlana Mactier, Nicola J. Armstrong, et al.
Clinical & Experimental Metastasis (2014) Vol. 31, Iss. 4, pp. 407-421
Open Access | Times Cited: 9
Development of a potent melanoma vaccine capable of stimulating CD8+ T-cells independently of dendritic cells in a mouse model
Katie Powell, Alexandre S. Stephens, Stephen J. Ralph
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 7, pp. 861-872
Open Access | Times Cited: 6
Melanoma vaccines
Lee B. Riley, Sanjiv S. Agarwala
Expert Review of Vaccines (2008) Vol. 7, Iss. 7, pp. 937-949
Closed Access | Times Cited: 7
In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells
Cindy Zuleger, Michael D. Macklin, Bret L. Bostwick, et al.
Journal of Immunological Methods (2010) Vol. 365, Iss. 1-2, pp. 76-86
Open Access | Times Cited: 5
Current World Literature

Current Opinion in Oncology (2008) Vol. 20, Iss. 2, pp. 234-244
Closed Access | Times Cited: 1
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients Kimberley L. KaufmanSwetlana MactierNicola J. Armstrong • Duthika MallawaaratchyScott N. ByrneLauren E. HayduValerie Jakrot • John F. ThompsonGraham J. MannRichard A. ScolyerRichard I. Christopherson
Kimberley L. Kaufman, Swetlana Mactier, Duthika M. Mallawaaratchy, et al.
(2014)
Closed Access
Modified Oncolytic Herpesviruses for Gene Therapy of Cancer
Shanthi Sivendran, Joe Goldufsky, Howard L. Kaufman, et al.
Elsevier eBooks (2013), pp. 213-223
Closed Access
NEVUS AND MELANOMA
Arlet E. Kurkchubasche, Thomas F. Tracy
Elsevier eBooks (2010), pp. 967-981
Closed Access
Page 1

Scroll to top